Andre Boulet - Devonian Health Chief Director
| GSD Stock | CAD 0.24 0.02 9.09% |
Director
Andre Boulet is Chief Director of Devonian Health Group
| Age | 66 |
| Address | 360, rue des Entrepreneurs, Québec, QC, Canada, G5V 4T1 |
| Phone | 514 248 7509 |
| Web | https://groupedevonian.com |
Devonian Health Management Efficiency
The company has return on total asset (ROA) of (0.0129) % which means that it has lost $0.0129 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0607) %, meaning that it generated substantial loss on money invested by shareholders. Devonian Health's management efficiency ratios could be used to measure how well Devonian Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Devonian Health's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to climb to about 7.2 M in 2025, whereas Other Current Assets are likely to drop 4,731 in 2025.Similar Executives
| Found 3 records | DIRECTOR Age | ||
| Jeffrey Straubel | Tesla Inc CDR | 48 | |
| Lawrence II | Alphabet Inc CDR | 52 | |
| Rodney Westmoreland | Tesla Inc CDR | N/A | |
Management Performance
| Return On Equity | -0.0607 | ||||
| Return On Asset | -0.0129 |
Devonian Health Group Leadership Team
Elected by the shareholders, the Devonian Health's board of directors comprises two types of representatives: Devonian Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Devonian. The board's role is to monitor Devonian Health's management team and ensure that shareholders' interests are well served. Devonian Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Devonian Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pierre Montanaro, CEO Pres | ||
| Andre Boulet, Chief Director | ||
| Viktoria Krasteva, Chief Officer | ||
| MSc CFA, VP Director |
Devonian Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Devonian Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0607 | ||||
| Return On Asset | -0.0129 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 25.39 M | ||||
| Shares Outstanding | 148.22 M | ||||
| Shares Owned By Insiders | 14.20 % | ||||
| Number Of Shares Shorted | 1.57 K | ||||
| Price To Book | 2.45 X | ||||
| Price To Sales | 1.59 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Devonian Stock Analysis
When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.